Annual CFF
$4.92 M
-$570.30 K-10.39%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual cash flow from financing activities is $4.92 million, with the most recent change of -$570.30 thousand (-10.39%) on December 31, 2023.
- During the last 3 years, COEP annual CFF has risen by +$2.02 million (+69.62%).
- COEP annual CFF is now -40.15% below its all-time high of $8.22 million, reached on December 31, 2021.
Performance
COEP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.48 M
-$468.60 K-24.11%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly cash flow from financing activities is $1.48 million, with the most recent change of -$468.60 thousand (-24.11%) on September 1, 2024.
- Over the past year, COEP quarterly CFF has dropped by -$276.40 thousand (-15.78%).
- COEP quarterly CFF is now -82.85% below its all-time high of $8.60 million, reached on September 1, 2021.
Performance
COEP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$6.73 M
+$1.70 M+33.78%
September 1, 2024
Summary
- As of February 8, 2025, COEP TTM cash flow from financing activities is $6.73 million, with the most recent change of +$1.70 million (+33.78%) on September 1, 2024.
- Over the past year, COEP TTM CFF has increased by +$1.82 million (+36.91%).
- COEP TTM CFF is now -42.42% below its all-time high of $11.69 million, reached on September 1, 2021.
Performance
COEP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
COEP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.4% | -15.8% | +36.9% |
| 3 y3 years | +69.6% | +38.1% | -8.0% |
| 5 y5 years | +69.6% | +38.1% | -8.0% |
COEP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | at low | -75.5% | +142.4% | -18.1% | +1452.3% |
| 5 y | 5-year | -40.1% | +69.6% | -82.8% | +142.4% | -42.4% | +1452.3% |
| alltime | all time | -40.1% | +69.6% | -82.8% | +142.4% | -42.4% | +1452.3% |
Coeptis Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.48 M(-24.1%) | $6.73 M(+33.8%) |
| Jun 2024 | - | $1.94 M(+24.4%) | $5.03 M(-22.3%) |
| Mar 2024 | - | $1.56 M(-10.8%) | $6.48 M(+31.8%) |
| Dec 2023 | $4.92 M(-10.4%) | $1.75 M(-878.7%) | $4.92 M(+1033.8%) |
| Sep 2023 | - | -$224.90 K(-106.6%) | $433.70 K(-93.5%) |
| Jun 2023 | - | $3.39 M(>+9900.0%) | $6.68 M(+53.3%) |
| Mar 2023 | - | $0.00(-100.0%) | $4.36 M(-20.5%) |
| Dec 2022 | $5.49 M | -$2.73 M(-145.3%) | $5.49 M(+15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $6.03 M(+464.2%) | $4.74 M(-35.2%) |
| Jun 2022 | - | $1.07 M(-5.2%) | $7.32 M(+6.8%) |
| Mar 2022 | - | $1.13 M(-132.4%) | $6.86 M(-16.6%) |
| Dec 2021 | $8.22 M(+183.4%) | - | - |
| Dec 2021 | - | -$3.48 M(-140.4%) | $8.22 M(-29.7%) |
| Sep 2021 | - | $8.60 M(+1329.8%) | $11.69 M(+278.5%) |
| Jun 2021 | - | $601.70 K(-75.8%) | $3.09 M(+24.2%) |
| Mar 2021 | - | $2.49 M | $2.49 M |
| Dec 2020 | $2.90 M | - | - |
FAQ
- What is Coeptis Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual CFF year-on-year change?
- What is Coeptis Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly CFF year-on-year change?
- What is Coeptis Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Coeptis Therapeutics?
- What is Coeptis Therapeutics TTM CFF year-on-year change?
What is Coeptis Therapeutics annual cash flow from financing activities?
The current annual CFF of COEP is $4.92 M
What is the all time high annual CFF for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual cash flow from financing activities is $8.22 M
What is Coeptis Therapeutics annual CFF year-on-year change?
Over the past year, COEP annual cash flow from financing activities has changed by -$570.30 K (-10.39%)
What is Coeptis Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of COEP is $1.48 M
What is the all time high quarterly CFF for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly cash flow from financing activities is $8.60 M
What is Coeptis Therapeutics quarterly CFF year-on-year change?
Over the past year, COEP quarterly cash flow from financing activities has changed by -$276.40 K (-15.78%)
What is Coeptis Therapeutics TTM cash flow from financing activities?
The current TTM CFF of COEP is $6.73 M
What is the all time high TTM CFF for Coeptis Therapeutics?
Coeptis Therapeutics all-time high TTM cash flow from financing activities is $11.69 M
What is Coeptis Therapeutics TTM CFF year-on-year change?
Over the past year, COEP TTM cash flow from financing activities has changed by +$1.82 M (+36.91%)